Loading people...
Anique ter Braake is an Associate in the Healthcare and Biotechnology team at M Ventures, based in Amsterdam, Netherlands. She evaluates and supports early-stage life sciences and therapeutics investments for the corporate venture capital arm of Merck KGaA, an entity that manages a fund allocation exceeding €600 million. Prior to assuming her current position, she initially joined the investment firm as an Analyst in February 2020, formally transitioning into the venture capital sector following an extensive academic research career. She holds a Ph.D. in Medical Sciences from Radboud University Medical Center, where she defended her thesis in 2020 and authored multiple peer-reviewed scientific publications focusing on magnesium, nephrology, and vascular calcification. Her current professional focus centers on leveraging her advanced biomedical research expertise to identify promising biotechnology startups and advance novel early-stage therapeutic innovations.
Anique ter Braake is a key member of the investment team at M Ventures, the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany. As an Associate, Anique plays a vital role in the firm's mission to invest in innovative early-stage companies that have the potential to significantly impact the future of life science and technology. Her work involves rigorous market research, deal sourcing, and comprehensive due diligence to identify promising startups that align with M Ventures' investment thesis and Merck's broader strategic objectives.
M Ventures is known for its deep expertise and commitment to fostering innovation in areas critical to human progress. Anique ter Braake's investment focus at M Ventures spans a range of high-growth sectors, including biotechnology, digital health, new modalities, platform technologies, and deep tech. This includes areas such as novel therapeutics, advanced diagnostics, innovative medical devices, artificial intelligence in healthcare, sustainable materials, and other disruptive technologies that can transform industries. She is dedicated to finding companies that are not only scientifically sound but also possess strong commercial viability and a clear path to market.
While specific details of her career background are not publicly detailed, professionals in Anique's role typically bring a strong foundation in science, engineering, or business, often coupled with experience in research, consulting, or startup environments. This background equips her with the analytical skills necessary to evaluate complex scientific and technological propositions, assess market potential, and understand the operational challenges faced by early-stage companies. Her contributions are instrumental in M Ventures' process of selecting and supporting ventures that are poised for significant growth and impact.
At M Ventures, Anique ter Braake collaborates closely with entrepreneurs, scientists, and industry experts to understand emerging trends and identify companies that are pushing the boundaries of innovation. While specific deal leads are often attributed to partners or principals, Anique plays a crucial role in the due diligence process and ongoing support for M Ventures' diverse portfolio companies. Her contributions help identify and nurture the next generation of innovators in life science and technology, ensuring that M Ventures continues to build a robust portfolio of groundbreaking companies that align with Merck's long-term vision. Her work helps bridge the gap between scientific discovery and commercial success, driving forward solutions that address some of the world's most pressing challenges.
Anique ter Braake is an Associate at M Ventures, the corporate venture capital arm of Merck KGaA, Darmstadt, Germany. She focuses on identifying and evaluating early-stage investment opportunities in life science and technology.
Anique ter Braake, through M Ventures, invests in early-stage companies across various high-growth sectors. Her focus areas include biotechnology, digital health, new modalities, platform technologies, and deep tech, all aligned with Merck's strategic interests.
Anique ter Braake works as an Associate at M Ventures, which is the corporate venture capital fund of Merck KGaA, Darmstadt, Germany.
